Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: engaged (185), occupied (51), unavailable (47)

InP RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab Ver1.1

Description: Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVE) Inpatient Regimen Regimen Lymphoma – InP-RIVE-Epiru
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab.pdf

Lisocel – Cyclophosphamide (300) – Fludarabine (30) Ver1

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) This reg
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lisocel-–-Cyclophosphamide-300-–-Fludarabine-30.pdf

Remuneration and Appointment Committee ToR March 2025

Description: Remuneration and Appointment Committee Terms of Reference Date Issued: 11 March 2025 Review Date: March 2026 Document Type
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Remuneration-and-Appointment-Committee-ToR-March-2025.pdf

SMILE

Description: Chemotherapy Protocol LYMPHOMA PEGAPARGASE-DEXAMETHASONE-ETOPOSIDE-IFOSFAMIDE-METHOTREXATE (SMILE) Inpatient Regimen Regimen Lymphoma – InP-SMILE-Pegasp
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/SMILE-Ver1.pdf

BRC Research-imaging-proposal-form_v1 FINAL 10.12.2024

Description: BRC Research Imaging Proposal form The BRC Research Imaging Proposal form should be completed by the chief/principal investigator of an
Url: /Media/Southampton-Clinical-Research/Grants/Download/BRC-Research-imaging-proposal-form-v1-FINAL-10.12.2024.docx

BRC Research-imaging-proposal-form_v1 FINAL 10.12.2024

Description: BRC Research Imaging Proposal form The BRC Research Imaging Proposal form should be completed by the chief/principal investigator of an
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-Research-imaging-proposal-form-v1-FINAL-10.12.2024.docx

Atezolizumab (1875mg 21-days) SC

Description: Chemotherapy Protocol UROTHELIAL CANCER Atezolizumab SC (1875mg – 21 days) Regimen • Urothelial cancer – Atezolizumab monotherapy (
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab-SC-1875mg-21-days.pdf

Cancer family history questionnaire

Description: Date ......................................... CANCER FAMILY HISTORY QUESTIONNAIRE Wessex Clinical Genetics Service Princess Anne Hospital Coxford Road Southampton SO16 5YA Tel: 023 8120 6170
Url: /Media/UHS-website-2019/Docs/Services/Genetics/Cancer-genetics/Cancer-family-history-questionnaire.pdf

Preparing your bladder and bowel for radiotherapy to the prostate or prostate bed - patient information

Description: This factsheet explains how to prepare your bladder and bowel for radiotherapy treatment to your prostate or prostate bed.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Preparing-your-bladder-and-bowel-for-radiotherapy-to-the-prostate-or-prostate-bed-603-PIL.pdf

Docetaxel-Pertuzumab-Trastuzumab Ver 1.3

Description: Chemotherapy Protocol BREAST CANCER DOCETAXEL-PERTUZUMAB-TRASTUZUMAB This protocol may require funding Regimen • Breast Cancer – Do
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Docetaxel-Pertuzumab-Trastuzumab.pdf

721 to 730 of 1000

Previous … 71 72 73 74 75 … Next